Skip to Main Content

Paper Details

MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas.
Nat Commun
7
2023
-, GDSC, MAPK, MAPK-related genes, MAPKi, MEKi, MSS, MSSs, Pediatric low-grade gliomas, cell lines, gene set, gliomas, immune cell, low-grade gliomas, microglia, microglia compartment, non, pLGG, pLGGs, patients, pediatric, sensitive cells, single-cell RNA, trametinib
Author NameAffiliation
David CapperBerlin Institute of Health
David CapperCharite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
David CapperBerlin Institute of Health
David CapperCharite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
Felix SahmHeidelberg University Hospital
Felix SahmClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ)
Felix SahmHeidelberg University Hospital
Felix SahmClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ)
Nada JabadoMcGill University
Nada JabadoMcGill University, and The Research Institute of the McGill University Health Centre
Nada JabadoMcGill University
Nada JabadoMcGill University
Nada JabadoMcGill University
Nada JabadoMcGill University, and The Research Institute of the McGill University Health Centre
Cornelis M van TilburgHopp Children's Cancer Center Heidelberg (KiTZ)
Cornelis M van TilburgHeidelberg University Hospital
Cornelis M van TilburgNational Center for Tumor Diseases (NCT)
Cornelis M van TilburgClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK)
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterGerman Cancer Research Center (DKFZ)
Stefan M PfisterHeidelberg University Hospital
Stefan M PfisterNational Center for Tumor Diseases (NCT)
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterNational Center for Tumor Diseases (NCT)
Stefan M PfisterHeidelberg University Hospital
Stefan M PfisterGerman Cancer Research Center (DKFZ)
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ)
Olaf WittHeidelberg University Hospital
Olaf WittNational Center for Tumor Diseases (NCT)
Olaf WittClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK)
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ)
Olaf WittClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK)
Olaf WittNational Center for Tumor Diseases (NCT)
Olaf WittHeidelberg University Hospital
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
Till MildeHopp Children's Cancer Center Heidelberg (KiTZ)
Till MildeClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK)
Till MildeNational Center for Tumor Diseases (NCT)
Till MildeHeidelberg University Hospital
  • 1 - 42

Datasets

Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink